Publications

5600 Results

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for mantle cell lymphoma: SWOG S0601

Authors
BG Till;H Li;S Bernstein;RI Fisher;RW Burack;LM Rimsza;J Floyd;M DaSilva;D Moore, Jr.;O Pozdnyakova;SM Smith;M Leblanc;JW Friedberg
Journal / Conference
British Journal of Haematology, Jan;172(2):208-218; 2015 Oct 22[Epub ahead of print]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID26492567
PMC
PMC4710555
Study Number(s)
S0601

SWOG S0709: Randomized phase II trial of erlotinib vs. erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay

Authors
P Lara;J Moon;P Hesketh;M Redman;SK Williamson;W Akerley;F Hirsch;P Mack;D Gandara
Journal / Conference
Journal of Thoracic Oncology, Mar;11(3):420-425; 2015 Dec 24[Epub ahead of print]
Year
2016
Research Committee(s)
Lung
PMID
PMID26725184
PMC
PMC4775366
Study Number(s)
S0709

A phase II study of belinostat (PXD101) in relapsed and refractory aggressive b-cell lymphomas: SWOG S0520

Authors
S Puvvada;H Li;D Persky;SH Bernstein;R Fisher;M Leblanc;M Schmelz;B Glinsmann-Gibson;TP Miller;J Friedberg;S Smith;L Rimsza
Journal / Conference
Leukemia & Lymphoma Oct;57(10):2359-2369; 2016 Jan 12:1-11 [Epub ahead of print]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID26758422
PMC
PMC5140034
Study Number(s)
S0520

Reduced intensity conditioning with high dose RTX yields excellent outcomes after allogeneic hematopoietic cell transplantation for relapsed follicular lymphoma: a phase II multicenter trial from the blood and marrow transplant network

Authors
G Laport;J Wu;B Logan;V Bachanova;C Hosing;T Fenske;W Longo;SM Devine;A Nademanee;I Gersten;M Horowitz;H Lazarus;M Riches Tomblyn
Journal / Conference
Biology of Blood and Marrow Transplantation Aug;22(8):1440-1448;2016 Apr 23 [Epub ahead of print]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27118571
PMC
PMC4949103

Patient income level and cancer clinical trial participation in a prospective survey study [Research Letter]

Authors
JM Unger;JR Gralow;KS Albain;S Ramsey;DL Hershman
Journal / Conference
JAMA Oncology, Jan 1;2(1):137-139
Year
2016
Research Committee(s)
Cancer Survivorship
PMID
PMID26468994
PMC
PMC4824189
Study Number(s)
S0316

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: Subset analysis of randomized trial intergroup S9704

Authors
SD Puvvada;P Stiff;M Leblanc;JR Cook;S Couban;JP Leonard;B Kahl;D Marcellus;T Shea;JN Winter;H Li;LM Rimsza;JW Friedberg;S Smith
Journal / Conference
British Journal of Haematology Sep;174(5):686-691; 2016 Apr 13 [Epub ahead of print]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27072903
PMC
PMC5125530
Study Number(s)
S9704

Non-steroidal anti-inflammatory drug use not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial

Authors
D Patel;J Schenk Kisser;A Darke;J Myers;W Brant;J Hotaling
Journal / Conference
British Journal of Urology International, Mar;117(3):500-506
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID26269564
PMC
PMC4826049
Study Number(s)
SWOG-9217

Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)

Authors
X Papanikolaou;A Rosenthal;M Dhodapkar;J Epstein;R Khan;F van Rhee;Y Jethava;S Waheed;M Zangari;A Hoering;J Crowley;D Alapat;F Davies;G Morgan;B Barlogie
Journal / Conference
Blood Cancer Journal 2016 Mar 25;6:e410. doi: 10.1038/bcj.2016.19
Year
2016
Research Committee(s)
Myeloma
PMID
PMID27015287
PMC
PMC4817101
Study Number(s)
S0120

Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial

Authors
T Murtola;B Gurel;M Umbehr;MS Lucia;IM Thompson;P Goodman;A Kristal;HL Parnes;SM Lippman;S Sutcliffe;S Peskoe;JR Barber;CG Drake;WG Nelson;AM DeMarzo;EA Platz
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention Mar;25(3):463-469
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID26715424
PMC
PMC4779655
Study Number(s)
SWOG-9217

Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT

Authors
JM Chan;A Darke;KL Penney;CM Tangen;P Goodman;K Jordahl;M Gwo-Shu Lee;T Sun;JM Rae;EA Klein;IM Thompson;PW Kantoff;LA Mucci
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention Jul;25(7):1050-1058
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27197287
PMC
PMC5086806
Study Number(s)
S0000